Literature DB >> 6731279

Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus.

A S Jaffe, J J Spadaro, K Schechtman, R Roberts, E M Geltman, B E Sobel.   

Abstract

To elucidate the factors involved in the reduced survival rate of diabetic patients after acute myocardial infarction (AMI), we prospectively evaluated 100 patients with well-documented diabetes and 426 control patients. We characterized infarct size and analyzed the incidence and severity of congestive heart failure (CHF) and subsequent death with respect to infarct size. The extent of the index infarct was less in diabetic compared to nondiabetic patients, 16.2 +/- 2.2 CK-gm-eq/m2 compared with 19.2 +/- 0.9 (p less than 0.02). However, CHF was more prevalent in diabetic patients (31.2% of the diabetic patients compared to 15.7%). The difference was most prominent in diabetic patients who had sustained prior infarction (50% compared to 16%), but was evident also in diabetic patients with initial infarction (26% compared to 16%). The mortality rate was greater in diabetic patients (p less than 0.04). When diabetic and nondiabetic patients were stratified with respect to the presence or absence of CHF, survival curves were comparable. The increased incidence of CHF despite a smaller infarct size suggests that additional factors must contribute to myocardial dysfunction and the resultant excess in mortality.

Entities:  

Mesh:

Year:  1984        PMID: 6731279     DOI: 10.1016/0002-8703(84)90541-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  35 in total

Review 1.  Emergency management of acute myocardial infarction.

Authors:  S Maxwell
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

Review 2.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

Review 3.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

4.  Insulin infusion in diabetic patients with acute myocardial infarction.

Authors:  G Davey; P Mckeigue
Journal:  BMJ       Date:  1996-09-14

5.  Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction.

Authors:  G A Oswald; C C Smith; A P Delamothe; D J Betteridge; J S Yudkin
Journal:  Br Heart J       Date:  1988-06

Review 6.  Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.

Authors:  P Camacho; S Pitale; C Abraira
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

7.  Myocardial infarct size and mortality in diabetic patients.

Authors:  D J Gwilt; M Petri; P W Lewis; M Nattrass; B L Pentecost
Journal:  Br Heart J       Date:  1985-11

8.  Diabetes and heart failure in patients with coronary disease: separating markers from mediators.

Authors:  Darren K McGuire; M Odette Gore; Frederick A Masoudi
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 17.152

9.  Effects of epinephrine on underperfusion-reperfusion injuries in diabetic and non-diabetic rat hearts.

Authors:  Makie Higuchi; Keiko Hirata; Ayako Yamashita; Katsuhide Nishi
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.